Heron Therapeutics, Inc.
Market Cap
85M
Short interest (May 15)
21.0%
Net Short (Jun 03 ): 1.2%
Borrow Fee
0.74%
↓ 5.5%
Available Shares
900K
↓ 57.0%
Price Chart
Company Overview
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.